Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
181 JPY | +2.84% | +1.12% | -4.74% |
2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
Sales * | - | Sales 1 * | - | Capitalization | 16.83B 107M 8.54B |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 0 | Net cash position 1 * | - 0 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | 17 |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 93.47% |
1 day | +2.84% | ||
1 week | +1.12% | ||
Current month | -2.16% | ||
1 month | -0.55% | ||
3 months | -3.72% | ||
6 months | +2.84% | ||
Current year | -4.74% |
Managers | Title | Age | Since |
---|---|---|---|
Shiro Akinaga
CEO | Chief Executive Officer | 67 | 31/05/20 |
Koji Fujimoto
DFI | Director of Finance/CFO | 51 | 31/10/02 |
Comptroller/Controller/Auditor | 61 | 30/11/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Satoru Iino
BRD | Director/Board Member | 58 | 29/02/12 |
Kazunori Kataoka
FOU | Founder | 73 | 13/06/96 |
Teruo Okano
FOU | Founder | 75 | 13/06/96 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 181 | +2.84% | 160 000 |
26/04/24 | 176 | -0.56% | 120,700 |
25/04/24 | 177 | -0.56% | 253,300 |
24/04/24 | 178 | -0.56% | 145,200 |
23/04/24 | 179 | -0.56% | 241,000 |
Delayed Quote Japan Exchange, April 30, 2024 at 07:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
-4.74% | 79.06M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.07% | 22.18B | |
-16.67% | 21.2B | |
-9.63% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- 4571 Stock